THE DEAL, AT A GLANCE
From the announcementFathom Therapeutics, Formerly Atommap,
01What happenedFathom Therapeutics, Formerly Atommap, raised $47M Series A, announced 2026-04-27From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Why it mattersFathom Therapeutics is using a Series A financing to translate physics and AI-enabled small molecule design into medicines within biotech and therapeutics.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Fathom Therapeutics, Formerly Atommap, · Financing Record
Explore source-linked visual explanations for Fathom Therapeutics, Formerly Atommap,. Unsupported claims are withheld while source review continues.
Record 3158 · Recorded date: 2026-04-27
Explore company records →